Reviewed By
Overview
SCIENTIFIC SCORE
Moderately Effective
Based on 22 Researches
8
USERS' SCORE
Good
Based on 5 Reviews
8.7
Supplement Facts
Serving Size: 1 Softgel
Serving Per Container: 30
Amount Per Serving
%DV
Calories
5
Total Fat
0.5 g
<1%¹
Total Omega-3 Fatty Acids
365 mg
DHA (Docosahexaenoic Acid)
350 mg
+
EPA (Eicosapentaenoic Acid)
15 mg
+
Top Medical Research Studies
We uncovered intriguing insights into how eicosapentaenoic acid (EPA) and its metabolite, 12-hydroxyeicosapentaenoic acid (12-HEPE), play a role in managing allergic responses, particularly in the skin. Our study revealed that when mice consumed an omega-3 fatty acid-rich diet, 12-HEPE became a significant metabolite in their skin.
Interestingly, we observed that the enzymes responsible for producing 12-HEPE were more active in the skin compared to other organs. This effective metabolite appeared to reduce inflammation caused by contact hypersensitivity. Specifically, we found that applying 12-HEPE topically limited the influx of neutrophils, a type of white blood cell involved in inflammatory responses.
Taking our research a step further, we investigated the effects of 12-HEPE on human skin cells, or keratinocytes, in lab conditions. Our findings showed that 12-HEPE inhibited two specific genes that cause neutrophils to be attracted to the site of inflammation, showcasing its potential as a therapeutic agent for allergy management. Overall, we identified 12-HEPE as a potent metabolite in the skin, suggesting that dietary omega-3 fatty acids could be a beneficial strategy in controlling allergic reactions.
Interestingly, we observed that the enzymes responsible for producing 12-HEPE were more active in the skin compared to other organs. This effective metabolite appeared to reduce inflammation caused by contact hypersensitivity. Specifically, we found that applying 12-HEPE topically limited the influx of neutrophils, a type of white blood cell involved in inflammatory responses.
Taking our research a step further, we investigated the effects of 12-HEPE on human skin cells, or keratinocytes, in lab conditions. Our findings showed that 12-HEPE inhibited two specific genes that cause neutrophils to be attracted to the site of inflammation, showcasing its potential as a therapeutic agent for allergy management. Overall, we identified 12-HEPE as a potent metabolite in the skin, suggesting that dietary omega-3 fatty acids could be a beneficial strategy in controlling allergic reactions.
Read More
9
We examined how docosahexaenoic acid, particularly its metabolite resolvin D2, influences allergic reactions and inflammation. Our focus was on type 2 inflammatory responses, often seen in allergic conditions. Through rigorous methodologies, including control groups, the study assessed how resolvin D2 can help in regulating these responses and promote the resolution of allergy-related inflammation in mice.
Our findings revealed that resolvin D2 plays a significant role in effectively managing allergic inflammation. It helps to mitigate the intense reactions typically associated with allergies, providing a clearer path toward alleviating symptoms.
This research demonstrates the potential of docosahexaenoic acid in offering therapeutic benefits for those suffering from type 2 inflammation due to allergies, and suggests that targeted treatments could improve overall allergen management.
Our findings revealed that resolvin D2 plays a significant role in effectively managing allergic inflammation. It helps to mitigate the intense reactions typically associated with allergies, providing a clearer path toward alleviating symptoms.
This research demonstrates the potential of docosahexaenoic acid in offering therapeutic benefits for those suffering from type 2 inflammation due to allergies, and suggests that targeted treatments could improve overall allergen management.
Read More
9
We explored the impact of dietary eicosapentaenoic acid (EPA) in children suffering from atopic dermatitis, a common allergic skin condition. In a well-structured study, forty-eight children were divided into two groups: one received 250 mg of EPA twice daily, while the other was given a placebo for four weeks.
The study aimed to measure the effectiveness of EPA by examining improvements in the SCORing Atopic Dermatitis (SCORAD) index and the need for topical corticosteroids. What we found was quite promising—after just two weeks, the EPA group showed significant improvement in their SCORAD scores compared to the placebo group.
Additionally, by the end of four weeks, fewer children in the EPA group required corticosteroids, indicating a potential reduction in the severity of their condition. Overall, the results suggest that EPA supplementation is both effective and well-tolerated among young patients with atopic dermatitis, offering a supportive strategy for managing this allergy-related issue.
The study aimed to measure the effectiveness of EPA by examining improvements in the SCORing Atopic Dermatitis (SCORAD) index and the need for topical corticosteroids. What we found was quite promising—after just two weeks, the EPA group showed significant improvement in their SCORAD scores compared to the placebo group.
Additionally, by the end of four weeks, fewer children in the EPA group required corticosteroids, indicating a potential reduction in the severity of their condition. Overall, the results suggest that EPA supplementation is both effective and well-tolerated among young patients with atopic dermatitis, offering a supportive strategy for managing this allergy-related issue.
Read More
Most Useful Reviews
9
No allergies experienced
1 people found this helpful
I took Raw Prenatal vitamins throughout my pregnancy and experienced no nausea. I had plenty of energy and needed less sleep than before. My baby was born healthy, and I'm currently taking DHA with the vitamins. The child has no allergies and is developing well; the benefits are clear. I highly recommend this to everyone!
Read More
9
No allergies noted
This omega is great for breastfeeding and did not cause any allergies while I was nursing.
Read More
9
Pleasant taste, no allergies
An excellent omega for nursing mothers, with a pleasant taste and subtle fish smell. The DHA dosage is optimal and, importantly, did not cause allergies in my baby!
Read More
Medical Researches
SCIENTIFIC SCORE
Moderately Effective
Based on 22 Researches
8
- All Researches
9.5
Docosahexaenoic acid helps asthma
We explored the potential of lipid mediators derived from docosahexaenoic acid (DHA) for alleviating allergic asthma. Using a model where mice were challenged with ovalbumin (OVA) to induce asthma-like symptoms, we administered lipid mediators that included 17S-monohydroxy DHA, resolvin D5, and protectin DX. These treatments led to significant improvements in key aspects of asthma such as reduced inflammatory cell infiltration and lower levels of Th2 cytokines.
Following treatment with the lipid mediators, we observed decreased levels of interleukin-6, tumor necrosis factor-α, and IgE—important markers associated with allergic reactions. There was a notable reduction in inflammation and oxidative stress in lung tissues, which suggests a protective effect on the lungs. Additionally, histological examinations revealed fewer signs of inflammation and mucus secretion.
The results indicate that DHA-derived lipid mediators may effectively mitigate the symptoms of allergic asthma and offer a promising new approach for treatment. They seem to act by reducing inflammation and improving antioxidant defenses within the lungs.
Following treatment with the lipid mediators, we observed decreased levels of interleukin-6, tumor necrosis factor-α, and IgE—important markers associated with allergic reactions. There was a notable reduction in inflammation and oxidative stress in lung tissues, which suggests a protective effect on the lungs. Additionally, histological examinations revealed fewer signs of inflammation and mucus secretion.
The results indicate that DHA-derived lipid mediators may effectively mitigate the symptoms of allergic asthma and offer a promising new approach for treatment. They seem to act by reducing inflammation and improving antioxidant defenses within the lungs.
Read More
9.5
We set out to assess a new extensively hydrolyzed whey-protein formula, which includes docosahexaenoic acid (DHA), for infants with cow's milk allergy (CMA). This study involved 34 children, primarily with IgE-mediated reactions, participating in a double-blind, placebo-controlled food challenge. Remarkably, all the children tolerated the new formula during the trial. This is significant since the American Academy of Pediatrics states that successful tolerance in over 90% of CMA children is crucial for a product to be considered hypoallergenic.
Although our focus was on the overall efficacy and safety of this formula, it's important to note that while DHA was included, we stopped short of isolating its specific impact on allergy outcomes. Thus, while we noted that this new formula is well-tolerated and associated with healthy growth and gastrointestinal tolerability, we cannot definitively state the effect of DHA alone on allergies. We recognize that further research would be needed to explore DHA's specific role in allergy management.
Although our focus was on the overall efficacy and safety of this formula, it's important to note that while DHA was included, we stopped short of isolating its specific impact on allergy outcomes. Thus, while we noted that this new formula is well-tolerated and associated with healthy growth and gastrointestinal tolerability, we cannot definitively state the effect of DHA alone on allergies. We recognize that further research would be needed to explore DHA's specific role in allergy management.
Read More
9
We explored how adding docosahexaenoic acid (DHA) and arachidonic acid (ARA) in the diets of allergy-prone Brown Norway rats affects allergy responses. Our study involved feeding these essential fatty acids to both mother rats and their pups during the crucial suckling and weaning periods.
By comparing groups that received these supplements to those that did not, we aimed to understand how these dietary changes might influence immune development and oral tolerance—the body’s ability to accept food without triggering an allergy.
At the end of our study, we found that the ARA + DHA supplementation during early life boosted DHA levels in the intestinal fats and increased important immunological markers such as secretory IgA and specific cytokines. This suggests that DHA and ARA may help create an environment in the gut that supports healthy immune responses and reduces allergy risk.
Overall, our findings highlight the potential benefits of these fatty acids for nurturing a more tolerant immune system in the early stages of life.
By comparing groups that received these supplements to those that did not, we aimed to understand how these dietary changes might influence immune development and oral tolerance—the body’s ability to accept food without triggering an allergy.
At the end of our study, we found that the ARA + DHA supplementation during early life boosted DHA levels in the intestinal fats and increased important immunological markers such as secretory IgA and specific cytokines. This suggests that DHA and ARA may help create an environment in the gut that supports healthy immune responses and reduces allergy risk.
Overall, our findings highlight the potential benefits of these fatty acids for nurturing a more tolerant immune system in the early stages of life.
Read More
9
We investigated how docosahexaenoic acid (DHA) influences allergic responses in conjunctival goblet cells, the cells that help maintain eye surface health. By stimulating human primary conjunctival goblet cells with histamine, we measured various lipid mediators in the extracellular vesicles they secreted.
Our findings revealed that in the presence of DHA during allergic inflammation, we observed a significant increase in two specialized pro-resolving mediators, LXA4 and RvD1. This increase was especially pronounced in female cells, showing respective fold increases of 5.3 and 6.9, while male responses remained markedly lower with only 0.5 and 0.8.
These results suggest that DHA not only enhances the production of beneficial mediators but also highlights a notable difference between male and female responses to allergic reactions. This novel insight could improve our understanding of allergy treatment, especially regarding why males may experience more severe allergic conjunctivitis.
Our findings revealed that in the presence of DHA during allergic inflammation, we observed a significant increase in two specialized pro-resolving mediators, LXA4 and RvD1. This increase was especially pronounced in female cells, showing respective fold increases of 5.3 and 6.9, while male responses remained markedly lower with only 0.5 and 0.8.
These results suggest that DHA not only enhances the production of beneficial mediators but also highlights a notable difference between male and female responses to allergic reactions. This novel insight could improve our understanding of allergy treatment, especially regarding why males may experience more severe allergic conjunctivitis.
Read More
9
We examined how docosahexaenoic acid, particularly its metabolite resolvin D2, influences allergic reactions and inflammation. Our focus was on type 2 inflammatory responses, often seen in allergic conditions. Through rigorous methodologies, including control groups, the study assessed how resolvin D2 can help in regulating these responses and promote the resolution of allergy-related inflammation in mice.
Our findings revealed that resolvin D2 plays a significant role in effectively managing allergic inflammation. It helps to mitigate the intense reactions typically associated with allergies, providing a clearer path toward alleviating symptoms.
This research demonstrates the potential of docosahexaenoic acid in offering therapeutic benefits for those suffering from type 2 inflammation due to allergies, and suggests that targeted treatments could improve overall allergen management.
Our findings revealed that resolvin D2 plays a significant role in effectively managing allergic inflammation. It helps to mitigate the intense reactions typically associated with allergies, providing a clearer path toward alleviating symptoms.
This research demonstrates the potential of docosahexaenoic acid in offering therapeutic benefits for those suffering from type 2 inflammation due to allergies, and suggests that targeted treatments could improve overall allergen management.
Read More
User Reviews
USERS' SCORE
Good
Based on 5 Reviews
8.7
- All Reviews
- Positive Reviews
- Negative Reviews
9
No allergies experienced
1 people found this helpful
I took Raw Prenatal vitamins throughout my pregnancy and experienced no nausea. I had plenty of energy and needed less sleep than before. My baby was born healthy, and I'm currently taking DHA with the vitamins. The child has no allergies and is developing well; the benefits are clear. I highly recommend this to everyone!
Read More
9
No allergies noted
This omega is great for breastfeeding and did not cause any allergies while I was nursing.
Read More
9
Pleasant taste, no allergies
An excellent omega for nursing mothers, with a pleasant taste and subtle fish smell. The DHA dosage is optimal and, importantly, did not cause allergies in my baby!
Read More
9
No allergies experienced
I took this Omega during my pregnancy and greatly appreciate this manufacturer; it did not cause any allergies.
Read More
9
Mild effect, no allergy
The product has a mild effect, and I experienced no allergies with it.
Read More
Frequently Asked Questions
9
No allergies experienced
1 people found this helpful
I took Raw Prenatal vitamins throughout my pregnancy and experienced no nausea. I had plenty of energy and needed less sleep than before. My baby was born healthy, and I'm currently taking DHA with the vitamins. The child has no allergies and is developing well; the benefits are clear. I highly recommend this to everyone!
9
Pleasant taste, no allergies
An excellent omega for nursing mothers, with a pleasant taste and subtle fish smell. The DHA dosage is optimal and, importantly, did not cause allergies in my baby!
9
No allergies noted
This omega is great for breastfeeding and did not cause any allergies while I was nursing.
9.5
Docosahexaenoic acid helps asthma
We explored the potential of lipid mediators derived from docosahexaenoic acid (DHA) for alleviating allergic asthma. Using a model where mice were challenged with ovalbumin (OVA) to induce asthma-like symptoms, we administered lipid mediators that included 17S-monohydroxy DHA, resolvin D5, and protectin DX. These treatments led to significant improvements in key aspects of asthma such as reduced inflammatory cell infiltration and lower levels of Th2 cytokines.
Following treatment with the lipid mediators, we observed decreased levels of interleukin-6, tumor necrosis factor-α, and IgE—important markers associated with allergic reactions. There was a notable reduction in inflammation and oxidative stress in lung tissues, which suggests a protective effect on the lungs. Additionally, histological examinations revealed fewer signs of inflammation and mucus secretion.
The results indicate that DHA-derived lipid mediators may effectively mitigate the symptoms of allergic asthma and offer a promising new approach for treatment. They seem to act by reducing inflammation and improving antioxidant defenses within the lungs.
Following treatment with the lipid mediators, we observed decreased levels of interleukin-6, tumor necrosis factor-α, and IgE—important markers associated with allergic reactions. There was a notable reduction in inflammation and oxidative stress in lung tissues, which suggests a protective effect on the lungs. Additionally, histological examinations revealed fewer signs of inflammation and mucus secretion.
The results indicate that DHA-derived lipid mediators may effectively mitigate the symptoms of allergic asthma and offer a promising new approach for treatment. They seem to act by reducing inflammation and improving antioxidant defenses within the lungs.
9
We explored how adding docosahexaenoic acid (DHA) and arachidonic acid (ARA) in the diets of allergy-prone Brown Norway rats affects allergy responses. Our study involved feeding these essential fatty acids to both mother rats and their pups during the crucial suckling and weaning periods.
By comparing groups that received these supplements to those that did not, we aimed to understand how these dietary changes might influence immune development and oral tolerance—the body’s ability to accept food without triggering an allergy.
At the end of our study, we found that the ARA + DHA supplementation during early life boosted DHA levels in the intestinal fats and increased important immunological markers such as secretory IgA and specific cytokines. This suggests that DHA and ARA may help create an environment in the gut that supports healthy immune responses and reduces allergy risk.
Overall, our findings highlight the potential benefits of these fatty acids for nurturing a more tolerant immune system in the early stages of life.
By comparing groups that received these supplements to those that did not, we aimed to understand how these dietary changes might influence immune development and oral tolerance—the body’s ability to accept food without triggering an allergy.
At the end of our study, we found that the ARA + DHA supplementation during early life boosted DHA levels in the intestinal fats and increased important immunological markers such as secretory IgA and specific cytokines. This suggests that DHA and ARA may help create an environment in the gut that supports healthy immune responses and reduces allergy risk.
Overall, our findings highlight the potential benefits of these fatty acids for nurturing a more tolerant immune system in the early stages of life.
8
We explored the potential of docosahexaenoic acid (DHA) in treating allergies by examining a study that focused on squid phospholipids extracted from Todarodes pacificus. The researchers analyzed these phospholipids' makeup and their impact on allergic reactions in models that mimic atopic dermatitis.
Notably, squid phospholipids contain a mix of components like phosphatidylethanolamine and phosphatidylcholine, with DHA as one of their key ingredients. Although the study showed improvements in allergy-like symptoms, the results specifically regarding DHA were less clear-cut.
In fact, when the study compared DHA and another component, soybean phosphatidylcholine, they found that neither significantly impacted the allergy symptoms in the mouse models. This leaves the effectiveness of DHA in isolation somewhat ambiguous.
Therefore, while the broader findings about squid phospholipids look promising for allergy treatment, we can't rightfully claim that DHA alone led to significant benefits. The research presents an intriguing area for future exploration in allergy management.
Notably, squid phospholipids contain a mix of components like phosphatidylethanolamine and phosphatidylcholine, with DHA as one of their key ingredients. Although the study showed improvements in allergy-like symptoms, the results specifically regarding DHA were less clear-cut.
In fact, when the study compared DHA and another component, soybean phosphatidylcholine, they found that neither significantly impacted the allergy symptoms in the mouse models. This leaves the effectiveness of DHA in isolation somewhat ambiguous.
Therefore, while the broader findings about squid phospholipids look promising for allergy treatment, we can't rightfully claim that DHA alone led to significant benefits. The research presents an intriguing area for future exploration in allergy management.
4
We explored the impacts of docosahexaenoic acid (DHA) and probiotics on the risk of allergic diseases in children. In a well-designed double-blind trial involving 439 expectant mothers, participants were divided into four groups: one receiving fish oil, another given probiotics, a third group taking both, and a control group with placebos.
While DHA is known for its health benefits, our findings indicated that neither fish oil nor probiotics significantly reduced the odds of developing childhood allergies. The notable exception was the probiotic group, which demonstrated a decrease in recurrent wheezing in children by the age of two.
This hints that there may be some potential in probiotics for reducing asthma risk as children grow. However, it’s important to recognize that DHA alone did not show a clear benefit in preventing allergies in infants, and further studies may clarify these outcomes.
While DHA is known for its health benefits, our findings indicated that neither fish oil nor probiotics significantly reduced the odds of developing childhood allergies. The notable exception was the probiotic group, which demonstrated a decrease in recurrent wheezing in children by the age of two.
This hints that there may be some potential in probiotics for reducing asthma risk as children grow. However, it’s important to recognize that DHA alone did not show a clear benefit in preventing allergies in infants, and further studies may clarify these outcomes.
References
- Su Y, Choi HS, Kwon SK, Han Y, Cho SC, et al. Lipid mediators obtained from docosahexaenoic acid by soybean lipoxygenase alleviate ovalbumin‑induced allergic asthma in mice by reducing airway inflammation and oxidative stress. Mol Med Rep. 2025;31. 10.3892/mmr.2025.13451
- Sato A, Sato G, Yabuki A, Ogawa Y, Nemoto H, et al. Ameliorative effects of squid phospholipids from Todarodes pacificus on atopic dermatitis-like lesions in NC/Nga mice. Arch Dermatol Res. 2025;317:239. 10.1007/s00403-024-03773-9
- Wang R, Patel D, Goruk S, Richard C, Field CJ. Feeding Docosahexaenoic Acid and Arachidonic Acid during Suckling and Weaning Contributes to Oral Tolerance Development by Beneficially Modulating the Intestinal Cytokine and Immunoglobulin Levels in an Allergy-Prone Brown Norway Rat Model. J Nutr. 2024;154:3790. 10.1016/j.tjnut.2024.10.021
- Lee C, Dartt DA. Sex-dependent differential increase of specialized pro-resolving mediators in extracellular vesicles secreted by human primary conjunctival goblet cells during allergic inflammation. Life Sci. 2024;357:123058. 10.1016/j.lfs.2024.123058
- Huang XW, Pang SW, Yang LZ, Han T, Chen JM, et al. TNFSF14 mediates the impact of docosahexaenoic acid on atopic dermatitis: a Mendelian randomization study. Eur Rev Med Pharmacol Sci. 2024;28:107. 10.26355/eurrev_202401_34896
- Peh HY, Brüggemann TR, Duvall MG, Nshimiyimana R, Nijmeh J, et al. Resolvin D2 regulates type 2 inflammatory responses and promotes resolution of mouse allergic inflammation. Allergy. 2024;79:739. 10.1111/all.15920
- Patel D, Munhoz J, Goruk S, Tsai S, Richard C, et al. Correction: Maternal diet supplementation with high-docosahexaenoic-acid canola oil, along with arachidonic acid, promotes immune system development in allergy-prone BALB/c mouse ofspring at 3 weeks of age. Eur J Nutr. 2024;63:341. 10.1007/s00394-023-03264-z
- Komulainen M, Saros L, Vahlberg T, Nermes M, Jartti T, et al. Maternal fish oil and/or probiotics intervention: Allergic diseases in children up to two years old. Pediatr Allergy Immunol. 2023;34:e14004. 10.1111/pai.14004
- Patel D, Munhoz J, Goruk S, Richard C, Field CJ. The Programming Effect of Plant-Based DHA, Along with Equivalent AA, on Immune System and Oral Tolerance Development in Six-Week Allergy Prone BALB/c Pups. J Nutr. 2023;153:2482. 10.1016/j.tjnut.2023.06.002
- Figueroa-Garduño I, Escamilla-Núñez C, Barraza-Villarreal A, Hernández-Cadena L, Onofre-Pardo EN, et al. Docosahexaenoic Acid Effect on Prenatal Exposure to Arsenic and Atopic Dermatitis in Mexican Preschoolers. Biol Trace Elem Res. 2023;201:3152. 10.1007/s12011-022-03411-3
- Dahdah L, Roelofs M, Knipping K, de Vries E, Rijnierse A, et al. Hypoallergenicity assessment of an extensively hydrolyzed whey-protein formula in cow's milk allergic infants. Pediatr Allergy Immunol. 2022;33:e13814. 10.1111/pai.13814
- Patel D, Goruk S, Richard C, Field CJ. Combined Supplementation with Arachidonic and Docosahexaenoic Acids in T Helper Type-2 Skewed Brown Norway Rat Offspring is Beneficial in the Induction of Oral Tolerance toward Ovalbumin and Immune System Development. J Nutr. 2022;152:2165. 10.1093/jn/nxac118
- Li SY, Zheng PY, Zhai YY, Zhang YD, Gan H, et al. [Analysis of the effect of early subcutaneous specific immunotherapy on the levels of dust mite allergen-specific antibodies and polyunsaturated fatty acid metabolism]. Zhonghua Yu Fang Yi Xue Za Zhi. 2024;58:778. 10.3760/cma.j.cn112150-20240124-00083
- Mirrahimi B, Moazemi M, Eslami N, Jamshidi E, Mir M, et al. Evaluating the Effect of Eicosapentaenoic Acid in Children With Atopic Dermatitis: A Randomized Triple-Blind Clinical Trial. J Pediatr Pharmacol Ther. 2023;28:29. 10.5863/1551-6776-28.1.29
- Imai T, Takada Y, Watanabe K. Effect of Omega-3 Polyunsaturated Fatty Acids Intake on Eosinophil Airway Inflammation in University Athletes. J Clin Med Res. 2022;14:466. 10.14740/jocmr4825
- Decsi T, Marosvölgyi T, Muszil E, Bódy B, Szabó É. Long-Chain Polyunsaturated Fatty Acid Status at Birth and Development of Childhood Allergy: A Systematic Review. Life (Basel). 2022;12. 10.3390/life12040526
- Saika A, Nagatake T, Hirata SI, Sawane K, Adachi J, et al. ω3 fatty acid metabolite, 12-hydroxyeicosapentaenoic acid, alleviates contact hypersensitivity by downregulation of CXCL1 and CXCL2 gene expression in keratinocytes via retinoid X receptor α. FASEB J. 2021;35:e21354. 10.1096/fj.202001687R
- Kanda N, Hoashi T, Saeki H. Nutrition and Atopic Dermatitis. J Nippon Med Sch. 2021;88:171. 10.1272/jnms.JNMS.2021_88-317
- Miles EA, Childs CE, Calder PC. Long-Chain Polyunsaturated Fatty Acids (LCPUFAs) and the Developing Immune System: A Narrative Review. Nutrients. 2021;13. 10.3390/nu13010247
- Barman M, Rabe H, Hesselmar B, Johansen S, Sandberg AS, et al. Cord Blood Levels of EPA, a Marker of Fish Intake, Correlate with Infants' T- and B-Lymphocyte Phenotypes and Risk for Allergic Disease. Nutrients. 2020;12. 10.3390/nu12103000
- Hoppenbrouwers T, Fogliano V, Garssen J, Pellegrini N, Willemsen LEM, et al. Specific Polyunsaturated Fatty Acids Can Modulate Human moDC2s and Subsequent Th2 Cytokine Release. Front Immunol. 2020;11:748. 10.3389/fimmu.2020.00748
- Saika A, Nagatake T, Kishino S, Park SB, Honda T, et al. 17(),18()-epoxyeicosatetraenoic acid generated by cytochrome P450 BM-3 from inhibits the development of contact hypersensitivity via G-protein-coupled receptor 40-mediated neutrophil suppression. FASEB Bioadv. 2020;2:59. 10.1096/fba.2019-00061
